United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir oral solution in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection. abacavir oral solution is contraindicated in patients: • who have the hla-b*5701 allele [see warnings and precautions ( 5.1)]. • with prior hypersensitivity reaction to abacavir [see warnings and precautions ( 5.1)]. • with moderate or severe hepatic impairment [see use in specific populations ( 8.6)]. teratogenic effects: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr)at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir compared with the

Kenya - English - Pharmacy and Poisons Board

cipla limited cipla house, peninsula business park, ganpatrao - abacavir sulfate usp lamivudine usp - dispersible tablet - abacavir sulfate- 120mg lamivudine- 60 mg - lamivudine and abacavir

Namibia - English - Namibia Medicines Regulatory Council

hetero labs limited - abacavir sulfate and lamivudine - tablets - each tablet contains abacavir sulfate 600,00 mg and lamivudine 300,00 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.76 mg (equivalent: abacavir, qty 600 mg) - tablet, film coated - excipient ingredients: sunset yellow fcf aluminium lake; magnesium stearate; microcrystalline cellulose; macrogol 8000; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; hypromellose - abacavir and lamivudine combination tablets are a combination of two nucleoside analogues (abacavir and lamivudine). ,abacavir and lamivudine combination tablets are indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.76 mg (equivalent: abacavir, qty 600 mg) - tablet, film coated - excipient ingredients: macrogol 8000; sunset yellow fcf aluminium lake; titanium dioxide; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; hypromellose; microcrystalline cellulose - abacavir and lamivudine combination tablets are a combination of two nucleoside analogues (abacavir and lamivudine). ,abacavir and lamivudine combination tablets are indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.76 mg (equivalent: abacavir, qty 600 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; titanium dioxide; croscarmellose sodium; macrogol 8000; colloidal anhydrous silica; sunset yellow fcf aluminium lake; magnesium stearate - abacavir and lamivudine combination tablets are a combination of two nucleoside analogues (abacavir and lamivudine). ,abacavir and lamivudine combination tablets are indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Uganda - English - National Drug Authority

cipla ltd. - abacavir sulfate + lamivudine - oral solid ordinary orally disintegrating tablets - 120mg + 60mg

Uganda - English - National Drug Authority

mylan laboratories limited - abacavir sulfate + lamivudine - oral solid ordinary soluble tablets - 120 mg + 60 mg

Zimbabwe - English - Medicines Control Authority

sun pharmaceutical industries limited - abacavir sulfate; lamivudine - tablet, coated; oral - 600; 300mg

Uganda - English - National Drug Authority

hetero labs ltd - abacavir sulfate + lamivudine - oral solid ordinary film-coated tablets - 600mg + 300mg